| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 374.1K | $3.11M | - | |
| CEO | 305.4K | $2.54M | - | |
| VP | 202.2K | $1.68M | - | |
| VP | 185.6K | $1.54M | - | |
| VP | 162.1K | $1.35M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2017 | Abdun-Nabi Daniel | President &CEO | Sale+OE | 15,000 | $37.21 | $558,150.00 | -6.8% | |
| Aug 31, 2017 | El-Hibri Fuad | Chairman | Sell | 5,461 | $37.50 | $204,787.50 | -0.3% | |
| Aug 15, 2017 | Hauer Jerome M | Director | Sale+OE | 10,776 | $35.83 | $386,149.34 | -36.6% | |
| Jul 27, 2017 | El-Hibri Fuad | Chairman | Sell | 25,000 | $36.50 | $912,500.00 | -1.5% | |
| Jul 20, 2017 | El-Hibri Fuad | Chairman | Sell | 25,000 | $35.50 | $887,500.00 | -1.5% | |
| Apr 3, 2017 | Havey Adam | EVP, Biodefense Divison | Sell | 11,419 | $28.62 | $326,808.35 | -30.5% | |
| Mar 8, 2017 | Hauer Jerome M | Director | Sell | 2,576 | $31.27 | $80,558.48 | -13.9% | |
| Jan 17, 2017 | Bailey Sue | Director | Sale+OE | 19,424 | $29.78 | $578,425.35 | -8.3% | |
| Jan 17, 2017 | Havey Adam | EVP, Biodefense Divison | Sell | 8,438 | $29.75 | $251,000.97 | -19.7% | |
| Jan 10, 2017 | Abdun-Nabi Daniel | President And CEO | Sale+OE | 28,240 | $31.28 | $883,296.37 | -13.0% |